Press Releases from Netris Pharma (1 total)
NETRIS Pharma successfully completes first clinical study with first-in-class ne …
Dose-escalation part of study met primary objective
Study shows NP137 to have excellent safety and tolerability profile
Preliminary efficacy seen during dose-escalation phase in uterine cancers
Lyon, France…
Go To Page:
